Pablo Aránguiz

612 total citations
19 papers, 523 citations indexed

About

Pablo Aránguiz is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Pablo Aránguiz has authored 19 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in Pablo Aránguiz's work include Cardiac Fibrosis and Remodeling (6 papers), Mitochondrial Function and Pathology (3 papers) and Connective Tissue Growth Factor Research (3 papers). Pablo Aránguiz is often cited by papers focused on Cardiac Fibrosis and Remodeling (6 papers), Mitochondrial Function and Pathology (3 papers) and Connective Tissue Growth Factor Research (3 papers). Pablo Aránguiz collaborates with scholars based in Chile, United States and Spain. Pablo Aránguiz's co-authors include Sergio Lavandero, Guillermo Dı́az-Araya, Rodrigo Troncoso, José M. Vicencio, Miguel Copaja, Raúl Vivar, Jimena Canales, Mario Chiong, Ivonne Olmedo and Beverly A. Rothermel and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Pablo Aránguiz

18 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Aránguiz Chile 12 260 159 139 68 63 19 523
Jieyun You China 14 243 0.9× 270 1.7× 117 0.8× 95 1.4× 57 0.9× 27 556
Dongwu Lai China 15 399 1.5× 233 1.5× 90 0.6× 45 0.7× 44 0.7× 31 683
Bingchao Qi China 11 384 1.5× 132 0.8× 92 0.7× 56 0.8× 88 1.4× 18 572
Fuqin Tang China 11 208 0.8× 82 0.5× 114 0.8× 57 0.8× 65 1.0× 22 424
Motoki Uchihashi Japan 6 251 1.0× 131 0.8× 128 0.9× 108 1.6× 56 0.9× 8 499
Kuniyoshi Fukai Japan 7 246 0.9× 138 0.9× 137 1.0× 117 1.7× 60 1.0× 13 511
Liang Xie United States 13 248 1.0× 116 0.7× 84 0.6× 46 0.7× 106 1.7× 20 568
Satoshi Kaimoto Japan 9 255 1.0× 182 1.1× 131 0.9× 114 1.7× 56 0.9× 14 558
Barbra Toro Chile 10 253 1.0× 87 0.5× 184 1.3× 49 0.7× 50 0.8× 11 490
Beilei Gao China 8 208 0.8× 90 0.6× 177 1.3× 52 0.8× 25 0.4× 9 452

Countries citing papers authored by Pablo Aránguiz

Since Specialization
Citations

This map shows the geographic impact of Pablo Aránguiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Aránguiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Aránguiz more than expected).

Fields of papers citing papers by Pablo Aránguiz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Aránguiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Aránguiz. The network helps show where Pablo Aránguiz may publish in the future.

Co-authorship network of co-authors of Pablo Aránguiz

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Aránguiz. A scholar is included among the top collaborators of Pablo Aránguiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Aránguiz. Pablo Aránguiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mella, Jaime, Pablo Aránguiz, Luis Espinoza, et al.. (2025). New Dimethoxyaryl-Sesquiterpene Derivatives with Cytotoxic Activity Against MCF-7 Breast Cancer Cells: From Synthesis to Topoisomerase I/II Inhibition and Cell Death Mechanism Studies. International Journal of Molecular Sciences. 26(10). 4539–4539.
2.
3.
4.
Mella, Jaime, Pablo Aránguiz, Luis Espinoza, et al.. (2023). Cytotoxic Activity, Topoisomerase I Inhibition and In Silico Studies of New Sesquiterpene-aryl Ester Derivatives of (-) Drimenol. Molecules. 28(9). 3959–3959. 3 indexed citations
5.
Niklander, Sven, Pablo Aránguiz, Fernando Faunes, & Rene Flores. (2023). Aging and oral squamous cell carcinoma development: the role of cellular senescence. SHILAP Revista de lepidopterología. 4. 1285276–1285276. 8 indexed citations
6.
7.
Vivar, Raúl, Claudio Humeres, Mabel Catalán, et al.. (2021). FoxO1 is required for high glucose-dependent cardiac fibroblasts into myofibroblast phenoconversion. Cellular Signalling. 83. 109978–109978. 13 indexed citations
8.
Aránguiz, Pablo, et al.. (2020). Polycystin-1 mitigates damage and regulates CTGF expression through AKT activation during cardiac ischemia/reperfusion. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(1). 165986–165986. 9 indexed citations
9.
Catalán, Mabel, Pablo Aránguiz, Pía Boza, et al.. (2019). TGF-β1 induced up-regulation of B1 kinin receptor promotes antifibrotic activity in rat cardiac myofibroblasts. Molecular Biology Reports. 46(5). 5197–5207. 6 indexed citations
10.
Olmedo, Ivonne, Jaime A. Riquelme, Pablo Aránguiz, et al.. (2019). Inhibition of the proteasome preserves Mitofusin-2 and mitochondrial integrity, protecting cardiomyocytes during ischemia-reperfusion injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(5). 165659–165659. 19 indexed citations
11.
Torrealba, Natalia, et al.. (2017). Mitochondria in Structural and Functional Cardiac Remodeling. Advances in experimental medicine and biology. 982. 277–306. 58 indexed citations
12.
Aránguiz, Pablo, Samir Bolívar, Claudio Humeres, et al.. (2017). Heparan sulfate potentiates leukocyte adhesion on cardiac fibroblast by enhancing Vcam-1 and Icam-1 expression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(3). 831–842. 33 indexed citations
13.
Olmedo, Ivonne, Claudia Muñoz, Mabel Catalán, et al.. (2013). EPAC expression and function in cardiac fibroblasts and myofibroblasts. Toxicology and Applied Pharmacology. 272(2). 414–422. 15 indexed citations
14.
Copaja, Miguel, Pablo Aránguiz, Jimena Canales, et al.. (2012). Simvastatin disrupts cytoskeleton and decreases cardiac fibroblast adhesion, migration and viability. Toxicology. 294(1). 42–49. 21 indexed citations
15.
Troncoso, Rodrigo, José M. Vicencio, Valentina Parra, et al.. (2011). Energy-preserving effects of IGF-1 antagonize starvation-induced cardiac autophagy. Cardiovascular Research. 93(2). 320–329. 118 indexed citations
16.
Copaja, Miguel, Pablo Aránguiz, Jimena Canales, et al.. (2011). Simvastatin induces apoptosis by a Rho-dependent mechanism in cultured cardiac fibroblasts and myofibroblasts. Toxicology and Applied Pharmacology. 255(1). 57–64. 36 indexed citations
17.
Aránguiz, Pablo, Jimena Canales, Miguel Copaja, et al.. (2010). Beta2-adrenergic receptor regulates cardiac fibroblast autophagy and collagen degradation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(1). 23–31. 111 indexed citations
18.
Aránguiz, Pablo, Dagoberto Soto, Ariel Contreras‐Ferrat, et al.. (2009). Differential Participation of Angiotensin II Type 1 and 2 Receptors in the Regulation of Cardiac Cell Death Triggered by Angiotensin II. American Journal of Hypertension. 22(5). 569–576. 14 indexed citations
19.
Vivar, Raúl, Miguel Copaja, Pablo Aránguiz, et al.. (2008). Phospholipase C/Protein Kinase C Pathway Mediates Angiotensin II-Dependent Apoptosis in Neonatal Rat Cardiac Fibroblasts Expressing AT1 Receptor. Journal of Cardiovascular Pharmacology. 52(2). 184–190. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jieyun You Breakdown of academic impact, for papers by Dongwu Lai Breakdown of academic impact, for papers by Bingchao Qi Breakdown of academic impact, for papers by Fuqin Tang Breakdown of academic impact, for papers by Motoki Uchihashi Breakdown of academic impact, for papers by Kuniyoshi Fukai Breakdown of academic impact, for papers by Liang Xie Breakdown of academic impact, for papers by Satoshi Kaimoto Breakdown of academic impact, for papers by Barbra Toro Breakdown of academic impact, for papers by Beilei Gao
Rankless by CCL
2026